Eterna Therapeutics Inc. (ERNA)

Eterna Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 1993
Net Income	-21.68	-24.6	-122.56	-7.29	-2.06	-0.28	-1.09	-2.92	-7.23	-5.03	Upgrade
Depreciation & Amortization	1.12	0.5	0.46	0.1	3.17	2.76	2.32	2.89	3.1	2.75	Upgrade
Share-Based Compensation	1.24	2.94	5.24	0.09	0.21	0.44	0.46	0.42	0.46	0.28	Upgrade
Other Operating Activities	-1.11	0.17	93.36	-1	1.42	-1.58	-1.15	-0.36	-0.51	-4.38	Upgrade
Operating Cash Flow	-20.41	-20.98	-23.49	-8.1	2.74	1.37	0.55	0.02	-4.18	-6.39	Upgrade
Operating Cash Flow Growth	-	-	-	-	101.03%	148.63%	2286.96%	-	-	-	Upgrade
Capital Expenditures	-0.02	-0.05	-0.15	-0.04	-1.09	-1.58	-1.45	-0.84	-1.62	-1.9	Upgrade
Acquisitions	0	0	-22.59	0	0	0	0	0	0	0	Upgrade
Other Investing Activities	-	-	-	-	0.03	-	-	-	-	-	Upgrade
Investing Cash Flow	-0.02	-0.05	-22.74	-0.04	-1.07	-1.58	-1.45	-0.84	-1.62	-1.9	Upgrade
Share Issuance / Repurchase	0.32	19.6	62.54	4.36	0	1.38	1.77	2.69	0	6.41	Upgrade
Debt Issued / Paid	16.25	-0	-0.94	0.31	-1.05	-1.62	-3.14	0.59	2.06	3.7	Upgrade
Other Financing Activities	-0.02	-0.01	-0.01	-	-0.05	-0.06	-0.1	-0.03	-0.08	-0.03	Upgrade
Financing Cash Flow	16.56	19.58	61.59	4.67	-1.1	-0.3	-1.47	3.26	1.98	10.08	Upgrade
Exchange Rate Effect	0	0	0	0	0.04	-0.08	0.06	0.02	-0.14	-0.07	Upgrade
Net Cash Flow	-3.87	-1.44	15.36	-3.47	0.62	-0.59	-2.37	2.44	-3.82	1.8	Upgrade
Free Cash Flow	-20.43	-21.02	-23.64	-8.14	1.65	-0.21	-0.9	-0.82	-5.8	-8.29	Upgrade
Free Cash Flow Margin	-30039.71%	-	-	-	8.33%	-0.92%	-4.24%	-3.66%	-23.67%	-31.81%	Upgrade
Free Cash Flow Per Share	-3.84	-6.89	-10.92	-9.26	22.96	-3.19	-14.79	-17.17	-126.29	-189.22	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).